Evidence map›Paper›PMID 22961852›Full record

ArticleJournal of bacteriology2012

SurA is involved in the targeting to the outer membrane of a Tat signal sequence-anchored protein.

Arnaud Rondelet, Guy Condemine

Abstract read
In one paragraph

Article in Journal of bacteriology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arnaud RondeletUniversité de Lyon, F69003, Université Lyon 1, F69622, INSA-Lyon F69621, France.
Guy Condemine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The twin arginine translocation (Tat) pathway exports folded proteins from the cytoplasm to the periplasm of bacteria. The targeting of the exported proteins to the Tat pathway relies on a specific amino-terminal signal sequence, which is cleaved after exportation. In the phytopathogen Dickeya dadantii, the pectin lyase homologue PnlH is exported by the Tat pathway without cleavage of its signal sequence, which anchors PnlH into the outer membrane. In proteobacteria, the vast majority of outer membrane proteins consists of β-barrel proteins and lipoproteins. Thus, PnlH represents a new kind of outer membrane protein. In Escherichia coli, periplasmic chaperones SurA, Skp, and DegP work together with the β-barrel assembly machinery (Bam) to target and insert β-barrel proteins into the outer membrane. In this work, we showed that SurA is required for an efficient targeting of PnlH to the outer membrane. Moreover, we were able to detect an in vitro interaction between SurA and the PnlH signal sequence. Since the PnlH signal sequence contains a highly hydrophobic region, we propose that SurA protects it from the hydrophobic periplasm during targeting of PnlH to the outer membrane. We also studied the nature of the information carried by the PnlH signal sequence responsible for its targeting to the outer membrane after exportation by the Tat system.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsBacterial Outer Membrane Proteinsbeta-GalactosidaseCarrier ProteinsEdetic AcidEscherichia coliEscherichia coli ProteinsGammaproteobacteriaGene Expression Regulation, BacterialGene Products, tatMolecular Sequence DataMutationPeptidylprolyl IsomerasePlant DiseasesProtein ConformationAnti-Bacterial AgentsBacterial Outer Membrane Proteinsbeta-GalactosidaseCarrier ProteinsEdetic AcidEscherichia coli ProteinsGene Products, tatPeptidylprolyl IsomeraseProtein Sorting SignalsRifampinSodium Dodecyl SulfateSurA protein, E coli

Identifiers

PMID22961852
PMCPMC3486411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.